You are here: Home Published Research Immunogenicity, impact on carriage and reactogenicity of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in Kenyan children aged 1-4 years: a randomized controlled trial.

Laura L Hammitt, John Ojal, Mahfudh Bashraheil, Susan C Morpeth, Angela Karani, Ahsan Habib, Dorota Borys, David Goldblatt, and J. AG Scott (2014)

Immunogenicity, impact on carriage and reactogenicity of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in Kenyan children aged 1-4 years: a randomized controlled trial.

PloS one, 9(1):e85459.

The impact on carriage and optimal schedule for primary vaccination of older children with 10-valent pneumococcal non-typeable Haemophilus influenzae protein-D conjugate vaccine (PHiD-CV) are unknown.

Antibodies, Bacterial, Bacterial Proteins, Carrier Proteins, Carrier State, Child, Preschool, Diphtheria-Tetanus-Pertussis Vaccine, Double-Blind Method, Female, Haemophilus Infections, Haemophilus Vaccines, Haemophilus influenzae, Hepatitis A Vaccines, Humans, Immunization Schedule, Immunization, Secondary, Immunoglobulin D, Infant, Infant, Newborn, Kenya, Lipoproteins, Male, Pneumococcal Infections, Pneumococcal Vaccines, Streptococcus pneumoniae, Vaccines, Conjugate
Antibodies, Bacterial, Bacterial Proteins, Carrier Proteins, Carrier State, Child, Preschool, Diphtheria-Tetanus-Pertussis Vaccine, Double-Blind Method, Female, Haemophilus Infections, Haemophilus Vaccines, Haemophilus influenzae, Hepatitis A Vaccines, Humans, Immunization Schedule, Immunization, Secondary, Immunoglobulin D, Infant, Infant, Newborn, Kenya, Lipoproteins, Male, Pneumococcal Infections, Pneumococcal Vaccines, Streptococcus pneumoniae, Vaccines, Conjugate
 
Document Actions